Thermo Fisher Hears B.R.A.H.M.S.
Wade Roush9/3/09
Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO), one of the world’s leading makers of diagnostic devices and lab equipment, said today that it has purchased Hennigsdorf, Germany-based B.R.A.H.M.S. for €330 million (US $470 million). B.R.A.H.M.S. is known for making a line of in vitro diagnostic tests based on patented biomarkers, including a test for sepsis widely used in Europe. A Thermo Fisher spokesperson said the acquisition would complement the company’s existing line of immunoassay testing products and give it “a significant reagent manufacturing footprint in Europe.”
